Christophe Nougier

Bron, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Point-of-care testing: presentation and methodology of a multidisciplinary working group

Point-of-care testing: presentation and methodology of a multidisciplinary working group

Journal: Annales de biologie clinique

Published: August 21, 2026

ROTEM PLATELET COMPONENT (A5 PLATELET) AS AN EARLY MARKER OF THROMBOCYTOPENIA AFTER SEVERE TRAUMA.

ROTEM PLATELET COMPONENT (A5 PLATELET) AS AN EARLY MARKER OF THROMBOCYTOPENIA AFTER SEVERE TRAUMA.

Journal: Thrombosis and haemostasis

Published: July 24, 2026

Impact of ROTEM on transfusion strategy in the management of coagulopathy during postpartum hemorrhage ≥1000 mL: a matched pre-post study.

Impact of ROTEM on transfusion strategy in the management of coagulopathy during postpartum hemorrhage ≥1000 mL: a matched pre-post study.

Journal: Minerva anestesiologica

Published: May 14, 2026

Acquired hemophilia A: an illustrated review based on the French National Guidelines.

Acquired hemophilia A: an illustrated review based on the French National Guidelines.

Journal: Research and practice in thrombosis and haemostasis

Published: April 19, 2026

Red blood cell Piezo1 Activation Drives Faster Coagulation and Structural Alterations in Blood Clots through Red Blood Cell Deformability Impairment.

Red blood cell Piezo1 Activation Drives Faster Coagulation and Structural Alterations in Blood Clots through Red Blood Cell Deformability Impairment.

Journal: Seminars in thrombosis and hemostasis

Published: April 01, 2026

Red Blood Cell Piezo1 Activation Drives Faster Coagulation and Structural Alterations in Blood Clots through Red Blood Cell Deformability Impairment.

Red Blood Cell Piezo1 Activation Drives Faster Coagulation and Structural Alterations in Blood Clots through Red Blood Cell Deformability Impairment.

Journal: Seminars in thrombosis and hemostasis

Published: April 01, 2026

A comprehensive multicenter study assessing the impact of abelacimab, asundexian, and milvexian on coagulation assays.

A comprehensive multicenter study assessing the impact of abelacimab, asundexian, and milvexian on coagulation assays.

Journal: Blood advances

Published: March 20, 2026

Unmet needs despite standard-of-care prophylaxis in Hemophilia A: improved outcomes after switching to Efanesoctocog Alfa.

Unmet needs despite standard-of-care prophylaxis in Hemophilia A: improved outcomes after switching to Efanesoctocog Alfa.

Journal: Blood advances

Published: March 13, 2026

In Vitro Study of the Role of Factor IX in Treatment of Breakthrough Bleeds in Patients with Hemophilia A and Inhibitors Receiving Emicizumab.

In Vitro Study of the Role of Factor IX in Treatment of Breakthrough Bleeds in Patients with Hemophilia A and Inhibitors Receiving Emicizumab.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: November 13, 2025

Recombinant FVIII Concentrates Show Distinct Stability Profiles During Heat Treatment Prior to Inhibitor Testing.

Recombinant FVIII Concentrates Show Distinct Stability Profiles During Heat Treatment Prior to Inhibitor Testing.

Journal: International journal of laboratory hematology

Published: November 03, 2025

Raising the D-dimer bar: a narrative review of the age-adjusted D-dimer threshold.

Raising the D-dimer bar: a narrative review of the age-adjusted D-dimer threshold.

Journal: Research and practice in thrombosis and haemostasis

Published: August 30, 2025

Utilising Thrombin Generation Assay to Guide Co-Administration of Factor Therapies With Fitusiran.

Utilising Thrombin Generation Assay to Guide Co-Administration of Factor Therapies With Fitusiran.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: June 02, 2025

Showing 1-12 of 58

Last Updated: 09/26/2026